Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer ; volume:13 ; number:9 ; day:27 ; month:9 ; year:2022 ; pages:1-14 ; date:9.2022
Cell death & disease ; 13, Heft 9 (27.9.2022), 1-14, 9.2022
- Urheber
-
Tang, Sangsang
Shen, Yuanming
Wei, Xinyi
Shen, Zhangjin
Lu, Weiguo
Xu, Junfen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-022-05257-y
- URN
-
urn:nbn:de:101:1-2022121520594593607689
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tang, Sangsang
- Shen, Yuanming
- Wei, Xinyi
- Shen, Zhangjin
- Lu, Weiguo
- Xu, Junfen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Classification of acute myeloid leukemia as a ferroptosis-sensitive malignancy suggesting the development of arsenic trioxide mediated ferroptosis-inducing combination therapies
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
Classification of acute myeloid leukemia as a ferroptosis-sensitive malignancy suggesting the development of arsenic trioxide mediated ferroptosis-inducing combination therapies
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
Classification of acute myeloid leukemia as a ferroptosis-sensitive malignancy suggesting the development of arsenic trioxide mediated ferroptosis-inducing combination therapies
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide